Profile
Michael E.
Markels worked as a Senior Director in Marketing at Biogen, Inc. in 2006.
He also worked as a Senior Director in Infectious Disease & Oncology at InterMune, Inc. in 2002.
From 1990 to 2001, he worked at Glaxo Wellcome, Inc. as a Director in Global Commercial Strategy.
He was also a Senior VP in Commercial & Business Development at NeurogesX, Inc. Mr. Markels holds an MBA from Duke University and an undergraduate degree from Colorado State University.
Former positions of Michael E. Markels
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Sales & Marketing | 2006-04-30 |
| INTERMUNE INC | Corporate Officer/Principal | 2002-09-30 |
Glaxo Wellcome, Inc.
Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Corporate Officer/Principal | 2000-12-31 |
| NEUROGESX, INC | Corporate Officer/Principal | - |
Training of Michael E. Markels
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
InterMune, Inc.
InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Colorado State University
Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeurogesX, Inc.
NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pain management therapies | Health Technology |
Glaxo Wellcome, Inc.
Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
- Stock Market
- Insiders
- Michael E. Markels
















